A Multi-Institutional Study of the Impact of the COVID-19 Pandemic on Diagnosis and Pharmacotherapy of Diabetic Macular Edema
Not Applicable
- Conditions
- Diabetic Macular Edema
- Registration Number
- JPRN-UMIN000048935
- Lead Sponsor
- niversity of Fukui Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 18305
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who refused to enroll in this study or who were participating in other clinical trials
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Association between the number of intravitreal injections of anti-VEGF drugs for diabetic macular edema after a COVID-19 outbreak (January 1, 2020 to March 18, 2022) and the number of new COVID-19 infections.
- Secondary Outcome Measures
Name Time Method